Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
PHASE2CompletedINTERVENTIONAL
Enrollment
79
Participants
Timeline
Start Date
February 17, 2021
Primary Completion Date
August 10, 2023
Study Completion Date
August 10, 2023
Conditions
Kaposiform Hemangioendothelioma
Interventions
DRUG
Sirolimus
Use of different doses of the same drug
Trial Locations (1)
610041
West China Hospital of Sichuan University, Chengdu
All Listed Sponsors
lead
West China Hospital
OTHER
NCT04775173 - Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma. | Biotech Hunter | Biotech Hunter